Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Daniela Spano,
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Oncology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
In the original article, we neglected to include the funder Italian Association for Cancer Research (AIRC, Milan, Italy), IG 2017 id. 20095 to Antonino Colanzi.
Antonino Colanzi was not included as an author in the published article. The corrected Author Contributions Statement appears below.
AC discussed and approved the manuscript.
With addition of Dr. Antonino Colanzi to the author list the Acknowledgement will be removed.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.